Anti-Prosurfactant Protein C 抗体 (ab90716)

ab90716 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab90716 は 8 報の論文で使用されています。

  • Wolf L  et al. Receptor for advanced glycation endproducts (RAGE) maintains pulmonary structure and regulates the response to cigarette smoke. PLoS One 12:e0180092 (2017). WB ; Mouse . PubMed: 28678851
  • Furukawa S  et al. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol 30:79-107 (2017). IHC ; Mouse . PubMed: 28190929
  • Pirazzoli V  et al. Afatinib plus Cetuximab Delays Resistance Compared to Single-Agent Erlotinib or Afatinib in Mouse Models of TKI-Naïve EGFR L858R-Induced Lung Adenocarcinoma. Clin Cancer Res 22:426-35 (2016). WB . PubMed: 26341921
  • Rydell-Törmänen K  et al. Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased ß-catenin inhibition and increased Wnt5a/b interaction. Physiol Rep 4:N/A (2016). IHC-P ; Human . PubMed: 26997628
  • Chen R  et al. Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs. J Biol Chem 290:30813-29 (2015). WB ; Mouse . PubMed: 26518879
  • Cross DA  et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov 4:1046-61 (2014). PubMed: 24893891
  • Rydell-Törmänen K  et al. Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma. Sci Rep 4:6383 (2014). Mouse . PubMed: 25230586
  • Takezawa K  et al. HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR-Mutant Lung Cancers That Lack the Second-Site EGFRT790M Mutation. Cancer Discov 2:922-933 (2012). PubMed: 22956644

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録